Pfizer launches new antibiotic in the UK
Pfizer’s antibiotic Zavicefta has now been launched in the UK to treat serious aerobic Gram-negative infections caused by resistant bacteria.
Read More
Tag: ceftazidime
US regulators expand use of Allergan’s antibiotic
The US Food and Drug Administration has agreed to expand the label of Dublin, Ireland-based Allergan’s Avycaz to include the treatment of complicated urinary tract infections (cUTI).
Read More
EU clears AstraZeneca’s new antibiotic
AstraZeneca’s Zavicefta has been approved for use in the European Union to treat patients with serious Gram-negative bacterial infections requiring hospitalisation.
Read More
- CERo reports encouraging early data from phase 1 trial of CER‑1236
- ENA Respiratory begins dosing in phase 2 study of INNA‑051 nasal spray
- Argo Biopharma doses first patient in phase 2b trial of BW‑20829
- Akari files new patent and advances second ADC targeting CEACAM5
- BioMed X launches kidney disease project in partnership with the government of Barbados
